Scinai Immunotherapeutics Ltd. (SCNI)
0.483
-0.02
(-3.40%)
USD |
NASDAQ |
Jun 02, 16:00
0.483
0.00 (0.00%)
After-Hours: 20:00
Scinai Immunotherapeutics Shareholders Equity (Quarterly) : 8.103M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 95.35M |
| Pluri, Inc. | -18.60M |
| Evogene Ltd. | -2.545M |
| CollPlant Biotechnologies Ltd. | 4.886M |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.63M |
| Total Liabilities (Quarterly) | 3.523M |
| Debt to Equity Ratio | 0.2798 |
| Current Ratio | 1.296 |
| Net Debt Paydown Yield | -8.42% |